A parliamentary committee has recommended the consolidation of all AYUSH drug-related standard-setting processes under a single independent drug controller in alignment with the Drugs and Cosmetics ...
Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.
Discover how the U.S. healthcare system has evolved over the years in terms of treatment outcomes, appropriate treatment, patient safety & preventive services.
The FDA relies on food companies to determine whether their ingredients are safe. Europe is tougher. At least 950 substances ...
The FDA’s GRAS rule lets companies decide if food additives are safe—without agency oversight. RFK Jr. now aims to close this ...
Indian Pharmaceutical Alliance says the study relies on FDA Adverse Event Reporting System data, which captures link between ...
Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
The FDA’s restraints on food ingredients are limited and relatively feeble, especially compared with those in Europe, a KFF Health News examination found.
Over the 50 years since UnitedHealth was founded, Richard T. Burke (81) has given few interviews. Now he has given an ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
THE Food and Drug Administration (FDA) has launched an online application process for Certificate of Medical Device ...
DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback